StageIncubator/Accelerator - II | Alive
Missing: ELXR's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ELXR's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing ELXR
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ELXR is included in 1 Expert Collection, including Omics.
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Latest ELXR News
Sep 19, 2020
Announces Postponement of Annual and Special Meeting of Shareholders MONTRÉAL, Sept. 18, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (“Elixxer” or the “Corporation”) (TSX-V: ELXR and OTC-QB: ELIXF) announces that it is postponing its annual and special meeting of shareholders (the “Meeting”). The Meeting had been scheduled for September 22, 2020. The Corporation intends to schedule a new date for the Meeting as soon as practicable. The Corporation will file an amended Management Information Circular (the “Circular”) on SEDAR in due course that will contain additional information that the Autorité des marchés financiers has requested to be included in the Circular in respect of certain matters to be considered at the Meeting. The Circular will also contain information on amended dates for proper submission of proxy voting instructions. About Elixxer Ltd. (www.elixxer.com)Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.For further information, please contact:Mazen Haddad, CEO: email@example.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Notice Regarding Forward Looking StatementsThis press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in Elixxer’s most recent Management’s Discussion and Analysis filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.
ELXR Frequently Asked Questions (FAQ)
When was ELXR founded?
ELXR was founded in 2018.
What is ELXR's latest funding round?
ELXR's latest funding round is Incubator/Accelerator - II.
Who are the investors of ELXR?
Investors of ELXR include Plug and Play Japan and 500 Kobe Accelerator.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.